Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. NMTC
NMTC logo

NMTC Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy NeuroOne Medical Technologies Corp (NMTC) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
3.310
1 Day change
1.69%
52 Week Range
6.960
Analysis Updated At
2026/06/12
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

NMTC is not a good buy right now for a beginner long-term investor with $50,000-$100,000 to deploy. The stock is pre-market at 3.24, but the technical trend is still weak, there is no strong proprietary buy signal today, and the recent analyst price target increase is mostly a reverse-split adjustment rather than a fresh fundamental upgrade. Based on the current data, I would not buy aggressively at this level.

Technical Analysis

The price is trading below the pivot level of 3.491 and near S1 at 3.25, which shows the stock is still testing support rather than breaking out. MACD histogram is negative at -0.0254 and still contracting, suggesting momentum remains weak. The moving average structure is bearish with SMA_200 > SMA_20 > SMA_5, indicating the broader trend is still down. RSI_6 at 20.089 is very oversold, but on its own it does not confirm a reversal. The similar-pattern trend data suggests modest near-term upside probability, but not enough to override the bearish trend structure.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Options sentiment looks bullish by open interest, with a put-call ratio of 0.2 showing far more calls than puts. However, actual option volume is zero today, so there is no active trading confirmation. Implied volatility is extremely high at 635.71 with IV rank 83.59 and IV percentile 99.21, which typically reflects very speculative pricing and elevated uncertainty. This makes the options market supportive in sentiment but not reliable as a clean entry signal.

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
8
Buy
1

Positive Catalysts

  • ["Ladenburg raised its price target to $8 and kept a Buy rating.", "Options open interest is skewed toward calls with a low put-call ratio of 0.2.", "The stock is oversold on RSI and trading near support, which could allow a rebound."]

Neutral/Negative Catalysts

  • ["No news in the recent week, so there is no fresh event-driven catalyst.", "The technical trend remains bearish with SMA_200 > SMA_20 > SMA_5.", "MACD is negative and still weakening.", "No strong Intellectia proprietary buy signal is present today.", "No significant hedge fund, insider, or congress trading activity was reported.", "The price target increase appears tied to the one-for-six reverse split, limiting its fundamental significance."]

Financial Performance

No financial snapshot was available because the data returned an error, so the latest quarter cannot be assessed from the provided information. The latest quarter season is therefore not available in the dataset.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Recent analyst action was constructive on the surface: Ladenburg lifted its target from $1.60 to $8 and maintained a Buy rating on 2026-05-13. However, the stated reason was the one-for-six reverse stock split, so the target change is mostly mechanical rather than a fresh upward revision in business fundamentals. Wall Street pros appear mildly positive on rating, but the rationale is not strongly supportive for a long-term beginner buyer.

Wall Street analysts forecast NMTC stock price to fall
1 Analyst Rating
Wall Street analysts forecast NMTC stock price to fall
1 Buy
0 Hold
0 Sell
Moderate Buy
Current: 3.305
sliders
Low
3
Averages
3
High
3
Current: 3.305
sliders
Low
3
Averages
3
High
3
Ladenburg
Buy
maintain
$8
AI Analysis
2026-05-13
Reason
Ladenburg
Price Target
$8
AI Analysis
2026-05-13
maintain
Buy
Reason
Ladenburg adjusted the firm's price target on NeuroOne Medical to $8 from $1.60 and keeps a Buy rating on the shares. It cites the one-for-six reverse stock split for the change.
JonesResearch
Justin Walsh
initiated
$1.50
2026-03-02
Reason
JonesResearch
Justin Walsh
Price Target
$1.50
2026-03-02
initiated
Reason
JonesResearch analyst Justin Walsh initiated coverage of NeuroOne Medical with a Buy rating and $1.50 price target. With a portfolio of four FDA-cleared products for the monitoring, recording, stimulation, and ablation of nervous tissue and support from distribution partner Zimmer Biomet (ZBH), the firm expects adoption of the OneRF Ablation System to continue at a steady pace, the analyst tells investors.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for NMTC
Unlock Now

People Also Watch